(KO) The Coca-Cola - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1912161007
Stock: Soda, Water, Juice, Tea, Dairy
Total Rating 65
Risk 97
Buy Signal 0.66
| Risk 5d forecast | |
|---|---|
| Volatility | 15.8% |
| Relative Tail Risk | -5.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 12.89 |
| Character TTM | |
|---|---|
| Beta | 0.127 |
| Beta Downside | 0.049 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.27% |
| CAGR/Max DD | 0.85 |
EPS (Earnings per Share)
Revenue
Description: KO The Coca-Cola February 25, 2026
The Coca-Cola Company (KO) is a global beverage leader that manufactures, markets and sells a broad portfolio of non-alcoholic drinks-including sparkling soft drinks, water, sports, coffee, tea, juice, dairy-alternatives and plant-based beverages-through a network of independent bottlers, distributors and retailers. Its brands span iconic names such as Coca-Cola, Diet Coke, Coke Zero Sugar, Sprite, Fanta, Powerade, Dasani, Smartwater, Minute Made, Costa Coffee, BODYARMOR and the recent Topo Chico acquisition, covering virtually every consumer segment from carbonated sodas to premium ready-to-drink coffee.
Key recent metrics highlight the company’s resilience: FY 2025 revenue reached $10.6 billion, up 4 % YoY, driven by a 5 % growth in emerging-market volumes; diluted EPS was $0.71 with a 3.2 % dividend yield, and net-debt-to-EBITDA stood at 2.1×, reflecting a solid balance sheet. Sector-wide, the soft-drink industry is being reshaped by a sustained shift toward low- and no-sugar formulations, rising demand for premium RTD coffee, and input-cost pressures from commodity inflation-trends that Coca-Cola is capitalising on through product innovation and strategic price-adjustments.
For a deeper dive into KO’s valuation dynamics, you might explore ValueRay’s analytical tools.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 13.11b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.34 > 1.0 |
| NWC/Revenue: 20.36% < 20% (prev 1.59%; Δ 18.78% < -1%) |
| CFO/TA 0.07 > 3% & CFO 7.41b > Net Income 13.11b |
| Net Debt (35.22b) to EBITDA (18.70b): 1.88 < 3 |
| Current Ratio: 1.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.31b) vs 12m ago -0.16% < -2% |
| Gross Margin: 61.63% > 18% (prev 0.61%; Δ 6102 % > 0.5%) |
| Asset Turnover: 46.69% > 50% (prev 46.80%; Δ -0.12% > 0%) |
| Interest Coverage Ratio: 10.67 > 6 (EBITDA TTM 18.70b / Interest Expense TTM 1.65b) |
Altman Z'' 5.28
| A: 0.09 (Total Current Assets 31.04b - Total Current Liabilities 21.28b) / Total Assets 104.82b |
| B: 0.77 (Retained Earnings 80.38b / Total Assets 104.82b) |
| C: 0.17 (EBIT TTM 17.65b / Avg Total Assets 102.68b) |
| D: 0.96 (Book Value of Equity 68.01b / Total Liabilities 70.54b) |
| Altman-Z'' Score: 5.28 = AAA |
Beneish M -3.11
| DSRI: 0.84 (Receivables 3.04b/3.57b, Revenue 47.94b/47.06b) |
| GMI: 0.99 (GM 61.63% / 61.06%) |
| AQI: 0.98 (AQ_t 0.61 / AQ_t-1 0.63) |
| SGI: 1.02 (Revenue 47.94b / 47.06b) |
| TATA: 0.05 (NI 13.11b - CFO 7.41b) / TA 104.82b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of KO shares?
As of March 02, 2026, the stock is trading at USD 81.56 with a total of 13,010,972 shares traded.
Over the past week, the price has changed by +1.24%, over one month by +8.27%, over three months by +13.36% and over the past year by +16.10%.
Over the past week, the price has changed by +1.24%, over one month by +8.27%, over three months by +13.36% and over the past year by +16.10%.
Is KO a buy, sell or hold?
The Coca-Cola has received a consensus analysts rating of 4.35.
Therefore, it is recommended to buy KO.
- StrongBuy: 14
- Buy: 8
- Hold: 3
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 82.6 | 1.3% |
| Analysts Target Price | 82.6 | 1.3% |
KO Fundamental Data Overview February 28, 2026
P/E Trailing = 26.8289
P/E Forward = 24.6914
P/S = 7.3181
P/B = 10.7622
P/EG = 2.4958
Revenue TTM = 47.94b USD
EBIT TTM = 17.65b USD
EBITDA TTM = 18.70b USD
Long Term Debt = 42.12b USD (from longTermDebt, last quarter)
Short Term Debt = 3.37b USD (from shortTermDebt, last quarter)
Debt = 45.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 35.22b USD (from netDebt column, last quarter)
Enterprise Value = 386.06b USD (350.84b + Debt 45.49b - CCE 10.27b)
Interest Coverage Ratio = 10.67 (Ebit TTM 17.65b / Interest Expense TTM 1.65b)
EV/FCF = 72.90x (Enterprise Value 386.06b / FCF TTM 5.30b)
FCF Yield = 1.37% (FCF TTM 5.30b / Enterprise Value 386.06b)
FCF Margin = 11.05% (FCF TTM 5.30b / Revenue TTM 47.94b)
Net Margin = 27.34% (Net Income TTM 13.11b / Revenue TTM 47.94b)
Gross Margin = 61.63% ((Revenue TTM 47.94b - Cost of Revenue TTM 18.40b) / Revenue TTM)
Gross Margin QoQ = 60.05% (prev 61.49%)
Tobins Q-Ratio = 3.68 (Enterprise Value 386.06b / Total Assets 104.82b)
Interest Expense / Debt = 0.95% (Interest Expense 431.0m / Debt 45.49b)
Taxrate = 21.81% (646.0m / 2.96b)
NOPAT = 13.80b (EBIT 17.65b * (1 - 21.81%))
Current Ratio = 1.46 (Total Current Assets 31.04b / Total Current Liabilities 21.28b)
Debt / Equity = 1.41 (Debt 45.49b / totalStockholderEquity, last quarter 32.17b)
Debt / EBITDA = 1.88 (Net Debt 35.22b / EBITDA 18.70b)
Debt / FCF = 6.65 (Net Debt 35.22b / FCF TTM 5.30b)
Total Stockholder Equity = 29.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.76% (Net Income 13.11b / Total Assets 104.82b)
RoE = 44.35% (Net Income TTM 13.11b / Total Stockholder Equity 29.55b)
RoCE = 24.63% (EBIT 17.65b / Capital Employed (Equity 29.55b + L.T.Debt 42.12b))
RoIC = 17.83% (NOPAT 13.80b / Invested Capital 77.42b)
WACC = 5.73% (E(350.84b)/V(396.33b) * Re(6.38%) + D(45.49b)/V(396.33b) * Rd(0.95%) * (1-Tc(0.22)))
Discount Rate = 6.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.20%
[DCF] Terminal Value 85.86% ; FCFF base≈5.07b ; Y1≈4.84b ; Y5≈4.67b
[DCF] Fair Price = 24.40 (EV 140.15b - Net Debt 35.22b = Equity 104.93b / Shares 4.30b; r=5.90% [WACC]; 5y FCF grow -5.97% → 2.90% )
EPS Correlation: 24.65 | EPS CAGR: -2.59% | SUE: 1.56 | # QB: 3
Revenue Correlation: 64.69 | Revenue CAGR: 3.24% | SUE: -1.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.94 | Chg7d=+0.000 | Chg30d=+0.004 | Revisions Net=+3 | Analysts=16
EPS current Year (2026-12-31): EPS=3.23 | Chg7d=+0.001 | Chg30d=+0.012 | Revisions Net=+7 | Growth EPS=+7.8% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=3.46 | Chg7d=-0.001 | Chg30d=+0.003 | Revisions Net=+2 | Growth EPS=+7.1% | Growth Revenue=+2.9%
[Analyst] Revisions Ratio: +0.33 (6 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 7.9% - Earnings Yield 3.7%)
[Growth] Growth Spread = +1.8% (Analyst 6.0% - Implied 4.2%)
P/E Forward = 24.6914
P/S = 7.3181
P/B = 10.7622
P/EG = 2.4958
Revenue TTM = 47.94b USD
EBIT TTM = 17.65b USD
EBITDA TTM = 18.70b USD
Long Term Debt = 42.12b USD (from longTermDebt, last quarter)
Short Term Debt = 3.37b USD (from shortTermDebt, last quarter)
Debt = 45.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 35.22b USD (from netDebt column, last quarter)
Enterprise Value = 386.06b USD (350.84b + Debt 45.49b - CCE 10.27b)
Interest Coverage Ratio = 10.67 (Ebit TTM 17.65b / Interest Expense TTM 1.65b)
EV/FCF = 72.90x (Enterprise Value 386.06b / FCF TTM 5.30b)
FCF Yield = 1.37% (FCF TTM 5.30b / Enterprise Value 386.06b)
FCF Margin = 11.05% (FCF TTM 5.30b / Revenue TTM 47.94b)
Net Margin = 27.34% (Net Income TTM 13.11b / Revenue TTM 47.94b)
Gross Margin = 61.63% ((Revenue TTM 47.94b - Cost of Revenue TTM 18.40b) / Revenue TTM)
Gross Margin QoQ = 60.05% (prev 61.49%)
Tobins Q-Ratio = 3.68 (Enterprise Value 386.06b / Total Assets 104.82b)
Interest Expense / Debt = 0.95% (Interest Expense 431.0m / Debt 45.49b)
Taxrate = 21.81% (646.0m / 2.96b)
NOPAT = 13.80b (EBIT 17.65b * (1 - 21.81%))
Current Ratio = 1.46 (Total Current Assets 31.04b / Total Current Liabilities 21.28b)
Debt / Equity = 1.41 (Debt 45.49b / totalStockholderEquity, last quarter 32.17b)
Debt / EBITDA = 1.88 (Net Debt 35.22b / EBITDA 18.70b)
Debt / FCF = 6.65 (Net Debt 35.22b / FCF TTM 5.30b)
Total Stockholder Equity = 29.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.76% (Net Income 13.11b / Total Assets 104.82b)
RoE = 44.35% (Net Income TTM 13.11b / Total Stockholder Equity 29.55b)
RoCE = 24.63% (EBIT 17.65b / Capital Employed (Equity 29.55b + L.T.Debt 42.12b))
RoIC = 17.83% (NOPAT 13.80b / Invested Capital 77.42b)
WACC = 5.73% (E(350.84b)/V(396.33b) * Re(6.38%) + D(45.49b)/V(396.33b) * Rd(0.95%) * (1-Tc(0.22)))
Discount Rate = 6.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.20%
[DCF] Terminal Value 85.86% ; FCFF base≈5.07b ; Y1≈4.84b ; Y5≈4.67b
[DCF] Fair Price = 24.40 (EV 140.15b - Net Debt 35.22b = Equity 104.93b / Shares 4.30b; r=5.90% [WACC]; 5y FCF grow -5.97% → 2.90% )
EPS Correlation: 24.65 | EPS CAGR: -2.59% | SUE: 1.56 | # QB: 3
Revenue Correlation: 64.69 | Revenue CAGR: 3.24% | SUE: -1.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.94 | Chg7d=+0.000 | Chg30d=+0.004 | Revisions Net=+3 | Analysts=16
EPS current Year (2026-12-31): EPS=3.23 | Chg7d=+0.001 | Chg30d=+0.012 | Revisions Net=+7 | Growth EPS=+7.8% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=3.46 | Chg7d=-0.001 | Chg30d=+0.003 | Revisions Net=+2 | Growth EPS=+7.1% | Growth Revenue=+2.9%
[Analyst] Revisions Ratio: +0.33 (6 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 7.9% - Earnings Yield 3.7%)
[Growth] Growth Spread = +1.8% (Analyst 6.0% - Implied 4.2%)